Form 4 for CLNN Clene Inc.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-16 · accession 0001562180-23-005321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-20 | 2023-06-16 | CLNN | MATLIN DAVID J | Dir | P - Purchase | $0.8 | +1.50M | 6.79M | +28% | +$1.20M |
| DM | 2023-06-20 | 2023-06-16 | CLNN | MATLIN DAVID J | Dir | A - Grant | — | +3.00M | 1.50M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | P | A | 1,500,000 | $0.8 | 6,793,684 | D | — | — | |
| 2 | Derivative | Warrants (Right to buy) | 2023-06-16 | A | A | 1,500,000 | — | 1,500,000 | D | $1.10 · 2023-06-16 to — | 1,500,000 Common Stock | (F2) The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. (F4) The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche A Warrant is for 1,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.10 per share. The Tranche A Warrant will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. |
| 3 | Derivative | Warrants (Right to buy) | 2023-06-16 | A | A | 1,500,000 | — | 1,500,000 | D | $1.50 · 2023-06-16 to — | 1,500,000 Common Stock | (F2) The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. (F3) The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche B Warrant is for 1,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.50 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. |